Transient neonatal myasthenia gravis: case report

Transient neonatal myasthenia gravis (TNMG) is a distinct type of myasthenia gravis (MG), a temporary autoimmune condition due to the mother’s antibodies crossing over the placenta and affecting the baby. Studies suggest that 10 to 15% of infants born to mothers suffering from MG will develop TNMG....

Full description

Bibliographic Details
Main Authors: Diana Iulia Vasilescu, Adriana Mihaela Dan, Vlad Dima, Monica Mihaela Cirstoiu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2022-12-01
Series:Romanian Medical Journal
Subjects:
Online Access:https://rmj.com.ro/articles/2022.4/RMJ_2022_4_Art-03.pdf
_version_ 1797328898660237312
author Diana Iulia Vasilescu
Adriana Mihaela Dan
Vlad Dima
Monica Mihaela Cirstoiu
author_facet Diana Iulia Vasilescu
Adriana Mihaela Dan
Vlad Dima
Monica Mihaela Cirstoiu
author_sort Diana Iulia Vasilescu
collection DOAJ
description Transient neonatal myasthenia gravis (TNMG) is a distinct type of myasthenia gravis (MG), a temporary autoimmune condition due to the mother’s antibodies crossing over the placenta and affecting the baby. Studies suggest that 10 to 15% of infants born to mothers suffering from MG will develop TNMG. Undoubtedly, if not diagnosed and treated in time, TNMG can be a serious condition, even life-threatening. Almost 80% of newborns will present symptoms in the first 24 hours of life that will last up to 4 weeks and a complete recovery is expected by 2 months of age. Only 10% of the affected infants may still be symptomatic at 4 months.
first_indexed 2024-03-08T06:58:36Z
format Article
id doaj.art-2c52499d2a824f83a4939a4b989a94d0
institution Directory Open Access Journal
issn 1220-5478
2069-606X
language English
last_indexed 2024-03-08T06:58:36Z
publishDate 2022-12-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Medical Journal
spelling doaj.art-2c52499d2a824f83a4939a4b989a94d02024-02-03T06:23:27ZengAmaltea Medical Publishing HouseRomanian Medical Journal1220-54782069-606X2022-12-0169416616810.37897/RMJ.2022.4.3Transient neonatal myasthenia gravis: case report Diana Iulia Vasilescu0Adriana Mihaela Dan1Vlad Dima2Monica Mihaela Cirstoiu3Doctoral School, ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Neonatology, Emergency University Hospital Bucharest, RomaniaDepartment of Neonatology, Emergency University Hospital Bucharest, RomaniaFilantropia Clinical Hospital, Bucharest, Romania”Carol Davila” University of Medicine and Pharmacy Bucharest, Romania; Department of Obstetrics and Gynecology, Emergency University Hospital Bucharest, RomaniaTransient neonatal myasthenia gravis (TNMG) is a distinct type of myasthenia gravis (MG), a temporary autoimmune condition due to the mother’s antibodies crossing over the placenta and affecting the baby. Studies suggest that 10 to 15% of infants born to mothers suffering from MG will develop TNMG. Undoubtedly, if not diagnosed and treated in time, TNMG can be a serious condition, even life-threatening. Almost 80% of newborns will present symptoms in the first 24 hours of life that will last up to 4 weeks and a complete recovery is expected by 2 months of age. Only 10% of the affected infants may still be symptomatic at 4 months.https://rmj.com.ro/articles/2022.4/RMJ_2022_4_Art-03.pdfmyasthenia gravisacetylcholine receptorantibodieshypotonianeostigmine
spellingShingle Diana Iulia Vasilescu
Adriana Mihaela Dan
Vlad Dima
Monica Mihaela Cirstoiu
Transient neonatal myasthenia gravis: case report
Romanian Medical Journal
myasthenia gravis
acetylcholine receptor
antibodies
hypotonia
neostigmine
title Transient neonatal myasthenia gravis: case report
title_full Transient neonatal myasthenia gravis: case report
title_fullStr Transient neonatal myasthenia gravis: case report
title_full_unstemmed Transient neonatal myasthenia gravis: case report
title_short Transient neonatal myasthenia gravis: case report
title_sort transient neonatal myasthenia gravis case report
topic myasthenia gravis
acetylcholine receptor
antibodies
hypotonia
neostigmine
url https://rmj.com.ro/articles/2022.4/RMJ_2022_4_Art-03.pdf
work_keys_str_mv AT dianaiuliavasilescu transientneonatalmyastheniagraviscasereport
AT adrianamihaeladan transientneonatalmyastheniagraviscasereport
AT vladdima transientneonatalmyastheniagraviscasereport
AT monicamihaelacirstoiu transientneonatalmyastheniagraviscasereport